tiprankstipranks
Trending News
More News >
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
US Market

Genscript Biotech (GNNSF) Technical Analysis

Compare
17 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Genscript Biotech’s (GNNSF) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Genscript Biotech is a Sell.
Genscript Biotech’s (GNNSF) 20-Day exponential moving average is 1.41, while Genscript Biotech’s (GNNSF) share price is $1.7, making it a Buy.
Genscript Biotech’s (GNNSF) 50-Day exponential moving average is 1.41, while Genscript Biotech’s (GNNSF) share price is $1.7, making it a Buy.

Genscript Biotech (GNNSF) Pivot Points

Jun 07, 2025, 07:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.67
1.67
1.67
1.67
1.67
1.67
1.67
Fibonacci
1.67
1.67
1.67
1.67
1.67
1.67
1.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genscript Biotech (GNNSF) Moving Averages

Jun 07, 2025, 07:03 AM
Period
Simple
Exponential
MA5
1.49Buy
1.54Buy
MA10
1.42Buy
1.47Buy
MA20
1.39Buy
1.41Buy
MA50
1.39Buy
1.41Buy
MA100
1.44Buy
1.42Buy
MA200
1.45Buy
1.43Buy
Genscript Biotech’s (GNNSF) 10-Day exponential moving average is 1.47, while Genscript Biotech’s (GNNSF) share price is $1.7, making it a Buy.
Genscript Biotech’s (GNNSF) 100-Day exponential moving average is 1.42, while Genscript Biotech’s (GNNSF) share price is $1.7, making it a Buy.
Genscript Biotech’s (GNNSF) stock price is $1.7 and Genscript Biotech’s (GNNSF) 50-day simple moving average is 1.39, creating a Buy signal.
Genscript Biotech’s (GNNSF) stock price is $1.7 and Genscript Biotech’s (GNNSF) 100-day simple moving average is 1.44, creating a Buy signal.
Genscript Biotech’s (GNNSF) stock price is $1.7 and Genscript Biotech’s (GNNSF) 200-day simple moving average is 1.45, creating a Buy signal.

Genscript Biotech (GNNSF) Technical Indicators

Jun 07, 2025, 07:03 AM
Name
Value
Implied Action
RSI (14)
92.24
Sell
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
66.67
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
21.89
Neutral
Williams %R
0.00
Sell
CCI (14)
349.94
Sell
ATR (14)
0.03
-
Ultimate Oscillator
100.15
Buy
ROC
25.00
Buy
Genscript Biotech’s (GNNSF) Relative Strength Index (RSI) is 92.24, creating a Sell signal.
Genscript Biotech’s (GNNSF) Trend Strength Indicator (ADX) is 21.89, creating a Neutral signal.
Genscript Biotech’s (GNNSF) Commodity Channel Index (CCI) is 349.94, creating a Sell signal.
Genscript Biotech’s (GNNSF) Price Rate of Change (ROC) is 25.00, creating a Buy signal.

FAQ

Is GNNSF a Buy, Hold, or Sell?
Based on GNNSF’s technical indicators, GNNSF is a Strong Buy.
    What is GNNSF’s RSI (14)?
    GNNSF’s RSI (14) is 92.24, which suggests GNNSF is a Sell.
      What is GNNSF’s MACD?
      GNNSF’s MACD is 0.05, which suggests GNNSF is a Sell.
        What is GNNSF’s 5-day moving average?
        GNNSF’s 5-day moving average is 1.49, which suggests GNNSF is a Buy.
          What is GNNSF’s 20-day moving average?
          GNNSF 20-day moving average is 1.39, which suggests GNNSF is a Buy.
            What is GNNSF’s 50-day moving average?
            GNNSF’s 50-day moving average is 1.39, which suggests GNNSF is a Buy.
              What is GNNSF’s 200-day moving average?
              GNNSF’s 200-day moving average is 1.45, which suggests GNNSF is a Buy.
                What is GNNSF’s Williams % R (14)?
                GNNSF’s Williams % R (14) is 0.00, which suggests GNNSF is a Sell.
                  What is GNNSF’s CCI (14)?
                  GNNSF’s CCI (14) is 349.94, which suggests GNNSF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis